Hospital Clínico San Carlos de Madrid -ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2021

  1. Obesity and telomere status in the prognosis of patients with colorectal cancer submitted to curative intention surgical treatment

    Molecular and Clinical Oncology, Vol. 15, Núm. 3

2017

  1. Telomeres and telomerase in the clinical management of colorectal cancer

    Clinical and Translational Oncology, Vol. 19, Núm. 4, pp. 399-408

2016

  1. Clinical relevance of telomere status and telomerase activity in colorectal cancer

    PLoS ONE, Vol. 11, Núm. 2

2015

  1. Prognostic value of telomere function in gastric cancers with and without microsatellite instability

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 2, pp. 162-169

  2. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status

    Journal of Experimental and Clinical Cancer Research, Vol. 34, Núm. 1

2014

  1. B-ring-aryl substituted luotonin A analogues with a new binding mode to the topoisomerase 1-DNA complex show enhanced cytotoxic activity

    PLoS ONE, Vol. 9, Núm. 5

2012

  1. Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition

    Oncology, Vol. 82, Núm. 3, pp. 153-164

  2. Methylation profiling in non-small cell lung cancer: Clinical implications

    International Journal of Oncology, Vol. 40, Núm. 3, pp. 739-746

2011

  1. Expression of human MDGA1 increases cell motility and cell-cell adhesion and reduces adhesion to extracellular matrix proteins in MDCK cells

    Cancer Microenvironment, Vol. 4, Núm. 1, pp. 23-32

2010

  1. MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway

    International Journal of Oncology, Vol. 36, Núm. 5, pp. 1209-1215